初诊不能切除的结直肠癌肝转移可能治愈吗？
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
目的探讨晚期结直肠癌肝转移的综合治疗方法。
Objective To inquirement late period cancer of colorectal synthesis treatment.
结论：结直肠癌肝转移是可以积极预防和治疗的。
Conclusion: Hepatic metastasis from colorectal cancer may energetic precaution and treating.
目的探讨同期治疗同时性结直肠癌肝转移的微创手术方法。
Objective To investigate the minimal invasive surgery for simultaneous treating synchronous colorectal liver metastasis.
结论：结直肠癌肝转移患者以手术为主的综合治疗安全有效。
Conclusion: Holistic therapy based on surgery for the treatment of colorectal cancer with hepatic metastasis was safety and efficacy.
结论：初诊不能切除的结直肠癌肝转移患者行缩小性化疗后再次切除，其治愈率可达16%。
Conclusion: Cure can be achieved overall in 16% of patients with initially unresectable CLM resected after downsizing chemotherapy.
包含在疫苗中的抗体被称作105AD7，已经在一结直肠癌肝转移生存7年的患者身上被克隆出。
The antibody contained in the vaccine, called 105AD7, was cloned from a patient who survived seven years with liver metastases from colorectal cancer, Durrant explained.
结果：对结直肠癌肝转移的治疗，已从消极对症治疗转为积极多途径的综合治疗，并取得了一定的效果。
Results: Rectal cancer with liver metastasis, through passively suit the medicine of the illness to turn into the energetic much methods syntheses treatment, moreover acquire specified effect.
目的：尽管目前肿瘤外科明显提高了不可切除的结直肠癌肝转移（CLM）患者的生存率，但治愈仍存在问题。
Purpose :Although oncosurgical strategies have demonstrated increased survival in patients with unresectable colorectal liver metastases (CLM), their potential for cure is still questioned.
目的探讨血管生成抑制剂YH - 16和氟尿嘧啶(5 - FU)联合应用对结直肠癌肝转移的抑制作用。
Objective to study the effect of angiogenesis inhibitor YH-16 in combination with 5-fu on liver metastasis of colorectal cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
结论CD 44和CD54可以作为临床早期诊断结直肠癌肝转移的生物学指标，同时也可以作为监测结直肠癌和结直肠癌肝转移预后的客观指标。
Conclusions CD44 and CD54 can be used as biological markers for early clinical diagnosis of liver metastasis and prognostic factor in colorectal cancer.
结果：该组49例结直肠癌患者原发癌均获切除，同时一期切除肝转移癌。
Results: All of 49 patients with colorectal cancer received one stage resection of primary tumors and metastatic tumors.
目的：探讨以奥沙利铂为主的肝动脉灌注化疗对结直肠癌多发肝转移患者的治疗效果。
AIM: To evaluate the efficacy of hepatic arterial infusion chemotherapy (HAIC) based on oxaliplatin for treatment of the patients with multiple liver metastases from colorectal cancer.
本文仅对目前结直肠癌及肝转移的术前辅助化疗进展做一综述。
This article reviewed the development of preoperative chemotherapy in colorectal cancer and liver metastasis.
结论：结直肠癌确诊时合并肝转移与肿瘤浸润深度、区域淋巴结有无转移、术前血cea、肿瘤标本巨检、腹膜及大网膜转移结节相关。
Conclusion: The tumor appearance, infiltration depth, lymph node metastasis, pre-operation serum CEA level, peritoneal or omentum metastasis were associated with metastases.
目的：探讨结直肠癌同时性肝转移的外科治疗效果。
Objective: To investigate the effect of surgical treatment on colorectal carcinoma with synchronous liver metastases.
结论：结、直肠癌较少转移至感染乙肝的肝脏，非感染乙肝的肝转移机率较大。
Conclusion: colorectal cancer rarely metastasizes to the liver infected with HbsAg; the chance of liver metastases of colorectal cancer is large for patients with HbsAg (-).
结论：结、直肠癌较少转移至感染乙肝的肝脏，非感染乙肝的肝转移机率较大。
Conclusion: colorectal cancer rarely metastasizes to the liver infected with HbsAg; the chance of liver metastases of colorectal cancer is large for patients with HbsAg (-).
应用推荐